DAMONA Pharmaceuticals™
Treat & Prevent Cognitive Deficits across Brain Disorders & During Aging

DAMONA Pharmaceuticals™ (formerly AlphaCog) is a preclinical pharma spinoff founded by the Centre for Addiction and Mental Health (CAMH) and Dr. Etienne Sibille. The mission of DAMONA Pharmaceuticals™ is to discover and develop small molecules for the treatment and prevention of cognitive symptoms in depression and other brain disorders.

Living With Dementia – Dr. Sibille presents how his work can help (CTV Your Morning)

Living With Dementia – Dr. Sibille presents how his work can help (CTV Your Morning) 150 150 Thomas Prevot

LIVING WITH DEMENTIA – CTV Your Morning  https://www.youtube.com/watch?v=8AVa1frLbyA From CTV Your Morning On September 16th, 2021, CTV Your Morning presented a media piece about memory loss and how CAMH contributes to tackling this…

What could prevent suicide? – Read the piece highlighting Dr. Sibille’s research from TORONTO STAR

What could prevent suicide? – Read the piece highlighting Dr. Sibille’s research from TORONTO STAR 150 150 Thomas Prevot

What could prevent suicide? For CAMH and mental health advocates, it’s advances in research and treatment. Article on TORONTO STAR What could prevent suicide? For CAMH and mental health advocates,…

What Happens to Our Brains When We Get Depressed?

What Happens to Our Brains When We Get Depressed? 150 150 Thomas Prevot

The human brain, in all its complexity, is nearly impossible to model. Neuroscientists are trying anyway. Illustration by Jeremy Leung The WALRUS, Canadian general-interest magazine published a new piece on…

Making old brain cells feel young again

Making old brain cells feel young again 1399 1127 Thomas Prevot

Find out more about Dr. Sibille’s research at camh, and how it relates to Research & Development in AlphaCog. Link to Camh Website Long before the technology existed that allows…

New Research Article shows Beneficial Effects of a New Drug in Transgenic Mouse Model with Cognitive Dysfunctions and Anxiety Phenotype

New Research Article shows Beneficial Effects of a New Drug in Transgenic Mouse Model with Cognitive Dysfunctions and Anxiety Phenotype 613 472 Thomas Prevot

The paper was published by Fee et al. in the International Journal of Neuropsychopharmacology. Patients suffering from mood and anxiety disorders often exhibit a deficit in brain inhibition. This deficit…

BBC World News

February 15, 2019

Dr. Etienne Sibille presented key findings on new compounds for cognitive dysfunction in depression and aging, live on BBC News, after the AAAS meeting in Washington D.C.